AMULET Innovality is Fujifilm’s flagship in digital mammography solutions. Images resulting from its innovative approach to tomosynthesis clinical application – two different acquisition modes, to better fulfil breast screening and diagnostic mammography needs – with unsurpassed 50 micron pixel size, will be shown together at the booth.
Canon Medical Systems Corporation enters the premium 1.5T MRI market with the launch of its new Vantage Orian system. Vantage Orian is one of Canon Medical Systems’ first major product releases since officially changing their company name from Toshiba Medical on January 4, 2018, and represents a major foray into the premium wide bore 1.5T market along with new technology designed to boost productivity, enhance patient comfort and deliver diagnostic clinical confidence to users and patients alike.
With a new slim gradient that delivers a gradient performance with a maximum amplitude of 45 mT/m, combined with a slew rate of 200 T/m/s that enhances high resolution and diffusion imaging, Vantage Orian offers high performance imaging capability previously not available on 1.5T systems from Canon Medical Systems and utilizes migrated high-end 3T technology. Canon Medical System’s PURERF and Saturn Gradient technology means that stable and consistent imaging performance is ensured, increasing signal to noise ratio (SNR) by up to 38%.
The Vantage Orian offers a range of new Rapid Scan and Easy Tech technology that reduces scan time and helps improve workflow. A redesigned gantry interface and dockable table ensure seamless patient handling. New applications like Multiband SPEEDER, that shortens acquisitions such as high angular resolution diffusion imaging (HARDI), and up to x8 accelerated k-t SPEEDER allows high frame rate cardiac cine and perfusion imaging with free breathing.
Vantage Orian also offers one of the smallest footprints in the 1.5T wide-bore class and low power consumption eco features that reduce energy use by up to 21%. The reliable system is equipped with excellent maintenance programs to satisfy the needs of hospital administrators.
A relaxed patient is key in MRI, and Vantage Orian features quiet scan sequences that reduce ambient noise by Pianissimo Zen technology. The 71cm wide bore and immersive virtual MR Theater are designed to put patients at ease. Vantage Orian also addresses challenging patients with Pediatric SPEEDER coils, contrast- free applications and ForeSee View for simplified scan planning.
Read more
Generally, endoscopic retrograde cholangiopancreatography (ERCP) procedures remain very safe for patients and allow the least-invasive manner for diagnosis and treatment for many biliopancreatic disorders and conditions. Yet, post-ERCP infections typically range between 2% and 4%. In August of this year, the FDA recommended healthcare facilities and manufacturers to begin transitioning to duodenoscopes with disposable components to reduce the risk of patient infection. A solution to the risk of infection, is to modify current endoscopes so that they have disposable parts. Especially the parts that are most receptable to contamination. Another solution would be to have disposable endoscopes. This of course introduces questions about pricing and the environmental impact which need to be solved by manufacturers and medical facilities before this solution can be used in daily practice.
PENTAX Medical recently introduced two innovative product solutions that reduce the risk for infection transmission. The DEC Duodenoscope (ED34-i10T2) aims to achieve this by eliminating the riskiest components of the endoscope, the distal end and elevator, and replacing it by a single-patient use sterile, disposable distal cap with integrated elevator. Additionally, using the PlasmaTYPHOON to ensure the device is fully dry reduces the risk for microbial growth and subsequent potential con-
tamination that can result from moisture. Drying endoscopes after reprocessing is recognized to be crucial for reducing the risk of infection.
Read more
A study published in the Journal of Diabetes Science and Technology found that “Quo-Lab met all criteria” and “has no bias compared to the mean of four secondary reference measurement procedures.”*
Quo-Lab is a semi-automated analyser designed to meet the needs of diabetes clinics and labs that demand low cost of operation and ease of use. It provides HbA1c results in four minutes using a small drop of blood.
EKF has developed Quo-Lab in conjunction with industry experts to deliver a product that meets the tightening requirements of NGSP certification and CAP EQA criteria.
Find out what Quo-Lab can do for your practice today.https://www.ekfdiagnostics.com/quo-lab.html
*Lenters-Westra E, English E. Evaluation of Four HbA1c Point-of-Care Devices Using International Quality Targets: Are They Fit for the Purpose? Journal of Diabetes Science and Technology. 2018; 12: 762-770.
Read more
Representing an evolution of the original detector-based IQon Spectral CT scanner, the IQon Elite advances the capabilities of its predecessor through a series of key benefits that support emergency/trauma department care and oncology care. This new configuration provides a number of enhanced features, including faster reconstruction speeds and better visualization of bone marrow pathology which increases diagnostic confidence within emergency and trauma departments, providing the opportunity to reduce the need for subsequent scans. The system’s ability to estimate electron density provides enhanced tissue characterization. IQon Elite’s faster reconstruction speeds have been shown to enable up to 200 CT patients per day. This is an important benchmark for healthcare facilities experiencing a high volume of patients, especially in the emergency department where CT can be a commonly-used imaging modality. The system’s new radiation therapy planning couch and bariatric table top allow larger patients to be scanned with increased positioning controls, providing greater clinical breadth.
Xenios AG, a company of the Fresenius Medical Care Group, reports that it has seen a significant growth in demand for its extracorporeal membrane oxygenation (ECMO) devices, which can be used for the treatment of patients who develop severe pneumonia and acute respiratory distress syndrome (ARDS) due to COVID-19 infection.
Jürgen Böhm, CMO of Xenios, explained that for critically ill COVID-19 patients with acute lung failure and refractory hypoxemia – despite use of standard therapy – “our treatment often remains the last therapeutic option and has been a lifesaver for many patients”.
Xenios’s ECMO therapy bypasses the function of the lungs. The patient’s blood is freed from carbon dioxide outside the body and enriched with oxygen. The lungs are thus given time to heal. Because of the increase of critically ill COVID-19 patients, more physicians are opting for ECMO therapy, and thus the increase in demand for Xenios’s ECMO devices.
To meet the demand, the company has increased production of its ECMO devices. “We have put many measures in place to maximize the utilization of our capacity to manufacture ECMO devices as well as patient kits. Our biggest challenge right now is the availability of specific components for our products,” said Andreas Terpin, CEO of Xenios.
For more information, visit: www.xenios-ag.com
Read more
Radiation measurement often requires different devices for varying applications adding to the cost and complexity of data collection. The new RaySafe 452 Survey Meter is a versatile, powerful tool that can be used for multiple situations, reducing the number of devices technicians need to carry, learn, and calibrate. The 452 Survey Meter is the ideal tool to measure radiation in a wide variety of applications, including wall leakage, scatted radiation in a room, tube leakage, nuclear medicine, and control of treated patients. The meter helps technicians make data collection accurately and easily with fast response times and detect variations from background radiation levels due to its high sensitivity. There is no need for post processing of the data due to a flat, wide energy response range. With the automatic saving of dose rate values every second data is easily saved to be analysed later. The RaySafe 452 features an optimized modern design that provides a big, clear, easy-to-read display with all the parameters in a single backlit display. Its ergonomic and lightweight design makes it easy to hold, carry, and use even over extended periods of time. And it has an IP 64 rating so it can easily be cleaned with water without damaging the device. The survey meter comes with RaySafe View software that makes it easy to transfer data to a PC and log data quickly, easily, and efficiently. All data is time stamped and dose rate waveforms can be further analysed later.
Read more
The Magnetom Sola Cardiovascular Edition is a 1.5 Tesla magnetic resonance imaging (MRI) scanner designed specifically for cardiovascular examinations.
Magnetom Sola Cardiovascular Edition incorporates the latest technologies with the specific aim of providing the maximum diagnostic information in cardiovascular examinations. This leads to faster, more reliable, and definitive diagnoses for a larger number of patients with underlying ischemic, structural, and arrhythmogenic conditions.
The MRI scanner’s innovative applications can cut examination times down to 20 minutes and clarify a broad range of clinical questions in cardiology. Guidelines issued by the European Society of Cardiology (ESC) have long described magnetic resonance imaging as the gold standard for assessing the morphology and function of the heart. Over 25 ESC Guidelines now contain specific recommendations describing instances where MRI should be used in cardiac diagnosis. This is primarily due to the accuracy of MRI when quantifying cardiac volume, mass, and wall motion, as well as its ability to diagnose ischemia and myocardial viability. There are also diseases such as myocarditis (inflammation of the heart muscle), for which cardiovascular MRI is the only non-invasive diagnostic option with the pre-requisite sensitivity. By receiving the right diagnosis at the right time, this group of patients can avoid unnecessary invasive procedures.
The Compressed Sensing Cardiac Cine application accelerates MRI scanning sequences so that cardiac function can be measured while the patient is breathing freely. Previous scanners required patients to hold their breath for up to 20 seconds several times during the process. This means that the benefits of the gold standard are now available to new groups of patients, including individuals with arrhythmia or dyspnea who were previously not eligible for CMR. The MyoMaps application provides quantitative information on the tissue composition of the cardiac muscle. This can be used to diagnose diseases of the heart muscle, scar tissue and edema at a very early stage of the condition, allowing the right treatment option to be chosen for the patient as soon as possible. Clinical conditions such as myocarditis can even be detected without using contrast agents. Cardiac Dot Engine is a unique software package which provides step-by-step guidance for standardized diagnostic cardiac MRI exams. It is based on artificial intelligence algorithms, allows users to navigate confidently through the cardiovascular MRI scanning process. Also, BioMatrix Technology automatically adjusts to the biovariability of different patients to prevent undesirable variations in the scanning process. As a result, BioMatrix Technology reduces examination times, cuts down on the number of repeat scans, and leads to consistent, high quality scanning results.
Read more
Breast Imaging
The 3Dimensions Mammography System is the industry’s fastest and highest resolution breast tomosynthesis system on the market. The system offers a variety of features designed to provide higher quality 3D images for radiologists, and enhanced workflow for technologists, with lowdose options, for patients. For example, the system includes Intelligent 2D imaging technology, which works with the system’s Clarity HD highresolution 3D imaging to deliver unprecedented clarity, contrast and detail at a lower dose.
Another feature available with the 3Dimensions system is the Quantra 2.2 breast density assessment software, which enables standardization in patient protocols, providing reproducible and consistent breast density assessment. Furthermore, thanks to the addition of the SmartCurve breast stabilization system, the 3Dimensions system is also clinically proven to deliver a more comfortable mammogram compared to standard compression, without compromising on speed, dose or accuracy.
Interventional
The Brevera® Breast Biopsy System with CorLumina® Imaging Technology is a real-time breast biopsy and verification system that improves the patient experience and streamlines the biopsy process from start to finish. Before the Brevera system, radiologists performing stereotactic breast biopsy procedures to diagnose breast cancer were often required to leave the patient under compression while they moved to another room to image and verify tissue samples. With the Brevera system, radiologists are able to obtain and image tissue samples in the procedure room in just a few seconds, potentially saving up to 10 minutes per patient and cutting the procedure time by up to 25%.
The Affirm® Prone Breast Biopsy System is the only dedicated prone biopsy system offering superior 2D or tomosynthesis imaging. Thanks to this high-quality 2D or tomosynthesis imaging and a field of view that’s more than 6.5 times larger than older generations of prone biopsy systems, clinicians can visualize more tissue and pinpoint subtle lesions and faint calcifications that may not be visible on older systems. Of note, more than 95% of patients reported their Affirm prone biopsy procedure was faster, more comfortable and less painful than expected. The system is designed with patients’ physical and emotional comfort in mind. Direct view of the biopsy needle is eliminated helping to reduce patient stress, and clinicians can quickly identify, target and access lesions to help reduce time spent in compression.
The Faxitron™ Core Specimen Radiography System is designed for efficiency. Within seconds this self-contained, table top unit provides highresolution imaging for immediate core sample verification in the biopsy room.
Breast Surgery
The LOCalizer™ Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System is a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. It was designed to replace the traditional wire-guided localization method, which requires placement of a wire on the day of surgery. With the tag, placement can be done weeks or months prior to surgery. For patients, this means they can arrive closer to their surgery time and experience fewer interventional procedures.
The Trident® HD Specimen Radiography System delivers enhanced image quality, improved workflow and instant sample verification during breastconserving surgeries and stereotactic breast biopsies. The Trident products are the only specimen radiographs on the market to use amorphous selenium direct capture imaging – the same detector technology used in Hologic’s 3Dimensions mammography system – to generate crisp, clear, high-resolution images.
Ultrasound
The Viera™ Portable Breast Ultrasound System is a wireless, handheld ultrasound device that delivers accurate, high-resolution diagnostic images at the point of care, enabling optimization of clinical workflow and patient pathway. The system seamlessly transmits images to smart devices and communication systems (PACS) in the office, exam room or surgical suite, and allows facilities to add interventional breast ultrasound services for a fraction of the cost of comparable cart systems. Additionally, the Supersonic Mach 30 Breast Ultrasound System provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display. The system’s enhanced ergonomics are designed to increase usability.
Read more
FibriCheck is a medically certified app (CE-class IIa and FDA-cleared) capable of detecting atrial fibrillation and other heart rhythm disorders, thereby preventing strokes. FibriCheck is leveraging mobile technologies for a better health. FibriCheck uses the built-in photoplethysmographic (PPG) sensors commonly found in smartphones and smartwatches to measure the rhythm of the user’s heartbeat. Employing medically-certified algorithms together with an artificially intelligent deep neural network, FibriCheck detects the presence of atrial fibrillation and other potentially fatal cardiac arrhythmias. It is as good as a 1-lead ECG and 96,5% accurate compared with a 12-lead ECG. By decentralizing the diagnostic process, FibriCheck is paving the way for broader access to effective care for individuals while reducing the total cost of healthcare for governments and insurers, thus helping to make Health 2.0 a reality for communities around the globe. FibriCheck is commercially available since May 2017, prescribed by over 1,200 doctors, used by over 110,000 people and reimbursed by selected healthcare funds.
Read more
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
